Permission to Cross Post

Thanks to Laurryn, Site Administrator http://dogsadversereactions.com/ for
this information:


<<
On 1/14/05 the FDA announced the "Joint Meeting of the Arthritis Advisory
Committee and the Drug Safety and Risk Management Advisory Committee"  to begin
meetings (3) ono 2/16/05. 
 
Again, the public is welcome to respond in person or by electronic comments. 
It does NOT specify human or animal, so I would presume it is for either.  As
you can see, the question of safety is the topic.  Comments MUST be received
by 2/4/05.
 
Your choices for response are:
 
"Electronic comments should be submitted to
http://www.fda.gov/dockets/ecomments. Select "2004N-0559-Overall Benefit to Risk
Considerations for COX-2
Selective Nonsteroidal Anti-inflammatory Drugs and Related Agents" and follow
the
prompts to submit your statement
 
Written comments should be submitted to the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852. Comments received by February 4, 2005, will be provided to the
committee before the meeting.
 
Contact People:  Kimberly Littleton Topper or Dornette Spell-LeSane, Center
for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600
Fishers Lane, (for express delivery, 5630 Fishers Lane, Rm. 1093) Rockville, MD
20857, 301-827-7001, FAX: 301-827-6801
 
E-mail: topperk@... or spelllesaned@... (but I am not sure
if they accept comments by email)
 
Your family, friends, associates........ a stranger on the street is also
welcome to respond with their opinion on the safety of these products.
 
The "Public" can be heard!

Laurryn~
"Got Dogs?"
http://www.dogsadversereactions.com/

To SAY nothing......... to DO nothing......... STOPS nothing!>>

Jean
(Always for George - Always for the Rimadyl Dogs)

A single voice may not be heard, but the voices of many cannot be ignored."
Author Unknown


[Non-text portions of this message have been removed]